alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 62, Number 50 (Friday, March 14, 1997)]
[Notices]
[Page 12256]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-6477]


-----------------------------------------------------------------------


NUCLEAR REGULATORY COMMISSION

Core Research Capabilities for the Office of Nuclear Regulatory 
Research; Meeting

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: NRC staff and industry will discuss the core research 
capabilities of the Office of Nuclear Regulatory Research.

DATES: March 25, 1997, 9:00 a.m.-4:00 p.m.

ADDRESSES: Room O-1F7/9, One White Flint North (OWFN) Building, 11545 
Rockville Pike, Rockville, MD.

FOR FURTHER INFORMATION CONTACT: Mr. Lloyd Donnelly, Office of Nuclear 
Regulatory Research, U.S. Nuclear Regulatory Commission, Washington DC 
20555 Telephone (301) 415-5828.

SUPPLEMENTARY INFORMATION: The purpose of this meeting is to discuss 
the core research capabilities of the Office of Nuclear Regulatory 
Research in order for this office to continue active participation in 
cooperative safety research activities with other government agencies 
including DOE, industry, and international organizations concerned with 
nuclear reactor safety.

    Dated at Rockville, Maryland, this 10th day of March 1997.

    For the Nuclear Regulatory Commission.
David L. Morrison,
Director, Office of Nuclear Regulatory Research.
[FR Doc. 97-6477 Filed 3-13-97; 8:45 am]
BILLING CODE 7590-01-P
**Exhibit 32.1**

 

# **CertificationPursuant to Section 1350 of Chapter 63**

**of Title 18 of the United States Code**

 

I, William M. Lasky,Interim President and Chief Executive Officer of Accuride Corporation, certifythat to my knowledge, (i) the Quarterly Report on Form 10-Q for theperiod ended September 30, 2008 fully complies with the requirements of Section 13(a) or15(d) of the Securities Exchange Act of 1934 and (ii) the informationcontained in the Quarterly Report on Form 10-Q for said period fairlypresents, in all material respects, the financial condition and results ofoperations of Accuride Corporation.

 
| /s/ WILLIAM M.  LASKY                          |   | Dated: | November 10,  2008 |
|------------------------------------------------|--------|--------|-------------------------|
| William M. Lasky                               |   |   |                    |
| Interim  President and Chief Executive Officer |   |   |                    |

 

 

I, David K. Armstrong,Senior Vice President / Chief Financial Officer of Accuride Corporation,certify that to my knowledge, (i) the Quarterly Report on Form 10-Qfor the period ended September 30, 2008 fully complies with therequirements of Section 13(a) or 15(d) of the Securities ExchangeAct of 1934 and (ii) the information contained in the Quarterly Report on Form 10-Qfor said period fairly presents, in all material respects, the financialcondition and results of operations of Accuride Corporation.

 
| /s/ DAVID K.  ARMSTRONG                          |   | Dated: | November 10,  2008 |
|--------------------------------------------------|--------|--------|-------------------------|
| David K.  Armstrong                              |   |   |                    |
| Senior Vice  President / Chief Financial Officer |   |   |                    |

 

----
No. 11-10519.

#### Profit *v.*Frederick, Warden.

C. A. 5th Cir. Certiorari denied.
July 2015

U.S. Energy Information Administration | Sales of Fossil Fuels Produced on Federal and Indian Lands, FY 2003 through FY 2014 16

Table 3. Sales of crude oil and lease condensate production from federal and Indian lands, FY 2003-14

million barrels

Notes: Totals may not equal sum of components because of independent rounding. Onshore federal excludes volumes on Indian 

lands. Offshore federal only includes areas in federal waters.

Source: U.S. Energy Information Administration based on U.S. Department of the Interior, Office of Natural Resources Revenue.

“ONNR Statistical Information Site” (http://statistics.onrr.gov).

Table 4. Sales of natural gas production from federal and Indian lands, FY 2003-14

billion cubic feet

Fiscal Year Offshore Federal Onshore Federal Total Federal Indian Lands

2003 4,522 2,276 6,798 283 

2004 4,025 2,351 6,376 312 

2005 3,523 2,534 6,057 327

2006 2,754 2,619 5,373 308 

2007 2,700 2,857 5,557 284 

2008 2,483 3,049 5,532 272 

2009 2,213 3,167 5,380 266 

2010 2,080 3,006 5,086 251 

2011 1,692 2,896 4,588 254 

2012 1,374 2,887 4,261 253

2013 1,198 2,637 3,835 241

2014 1,069 2,482 3,551 241

Notes: Totals may not equal sum of components because of independent rounding. Onshore federal excludes volumes on 

Indian lands. Offshore federal only includes areas in federal waters.

Source: U.S. Energy Information Administration based on U.S. Department of the Interior, Office of Natural Resources Revenue.

“ONNR Statistical Information Site” (http://statistics.onrr.gov).

Fiscal Year Offshore Federal Onshore Federal Total Federal Indian Lands

2003 579 100 679 10 

2004 572 97 670 10 

2005 541 96 638 10 

2006 471 100 571 10 

2007 514 104 618 10 

2008 462 103 565 10 

2009 544 105 649 10 

2010 616 108 724 13 

2011 532 113 645 20 

2012 476 125 601 31 

2013 476 137 614 46 

2014 502 149 651 56
No. 11-10884.

#### Rivera-Velez *v.*United States.

C. A. 3d Cir. Certiorari denied.
[Federal Register Volume 62, Number 50 (Friday, March 14, 1997)]
[Notices]
[Page 12200]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-6596]


-----------------------------------------------------------------------


FEDERAL RESERVE SYSTEM

Sunshine Act Meeting

TIME AND DATE: Approximately 10:15 a.m., Wednesday, March 19, 1997, 
following a recess at the conclusion of the open meeting.

PLACE: Marriner S. Eccles Federal Reserve Board Building, C Street 
entrance between 20th and 2lst Streets, NW., Washington, DC 20551.

STATUS: Closed.

MATTERS TO BE CONSIDERED:

    1. Personnel actions (appointments, promotions, assignments, 
reassignments, and salary actions) involving individual Federal Reserve 
System employees.
    2. Any items carried forward from a previously announced meeting.

CONTACT PERSON FOR MORE INFORMATION: Mr. Joseph R. Coyne, Assistant to 
the Board; (202) 452-3204. You may call (202) 452-3207, beginning at 
approximately 5 p.m. two business days before this meeting, for a 
recorded announcement of bank and bank holding company applications 
scheduled for the meeting.

    Dated: March 12, 1997.
Jennifer J. Johnson,
Deputy Secretary of the Board.
[FR Doc. 97-6596 Filed 3-12-97; 11:06 am]
BILLING CODE 6210-01-P
[ARTICLE] 5
<TABLE>
<S>                             <C>
[PERIOD-TYPE]                   6-MOS
[FISCAL-YEAR-END]                          MAR-31-2000
[PERIOD-END]                               SEP-30-1999
[CASH]                                          963841
[SECURITIES]                                         0
[RECEIVABLES]                                  6553555
[ALLOWANCES]                                    180000
[INVENTORY]                                    6272788
[CURRENT-ASSETS]                               1074405
[PP&E]                                        12853761
[DEPRECIATION]                                       0
[TOTAL-ASSETS]                                28230103
[CURRENT-LIABILITIES]                         11560098
[BONDS]                                              0
[COMMON]                                         91839
[PREFERRED-MANDATORY]                                0
[PREFERRED]                                          0
[OTHER-SE]                                    14414599
[TOTAL-LIABILITY-AND-EQUITY]                  28230103
[SALES]                                       20902705
[TOTAL-REVENUES]                              20902705
[CGS]                                         13312726
[TOTAL-COSTS]                                  5830356
[OTHER-EXPENSES]                                     0
[LOSS-PROVISION]                                     0
[INTEREST-EXPENSE]                              325516
[INCOME-PRETAX]                                1430404
[INCOME-TAX]                                     30000
[INCOME-CONTINUING]                            1400404
[DISCONTINUED]                                       0
[EXTRAORDINARY]                                      0
[CHANGES]                                            0
[NET-INCOME]                                   1400404
[EPS-BASIC]                                     0.15
[EPS-DILUTED]                                     0.15
</TABLE>
# C_2022119EN.01005101.xml

| 14.3.2022 | EN | Official Journal of the European Union | C 119/51 |
| --- | --- | --- | --- |

14.3.2022

EN

Official Journal of the European Union

C 119/51

---

Action brought on 18 January 2022 — Sanoptis v EUIPO — Synoptis Pharma (SANOPTIS)

(Case T-30/22)

(2022/C 119/73)

Language of the case: English

Parties

Applicant: Sanoptis Sàrl (Luxembourg, Luxembourg) (represented by: S. Rost, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Synoptis Pharma sp. z o.o. (Warsaw, Poland)

Details of the proceedings before EUIPO

Applicant of the trade mark at issue: Applicant before the General Court

Trade mark at issue: Application for European Union word mark SANOPTIS — Application for registration No 17 934 770

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 18 November 2021 in Case R 850/2021-4

Form of order sought

The applicant claims that the Court should:

| — | annul the contested decision; |
| --- | --- |

—

annul the contested decision;

| — | order EUIPO to bear its own costs and to pay those incurred by the applicant; |
| --- | --- |

—

order EUIPO to bear its own costs and to pay those incurred by the applicant;

| — | orders the intervener to bear its own costs. |
| --- | --- |

—

orders the intervener to bear its own costs.

Pleas in law

| — | Infringement of Article 94(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council in the failure to state reasons in the contested decision; |
| --- | --- |

—

Infringement of Article 94(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council in the failure to state reasons in the contested decision;

| — | Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |
| --- | --- |

—

Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.

---
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 9010 Introduced in House (IH)]

<DOC>

116th CONGRESS
  2d Session
                                H. R. 9010

 To direct the Secretary of Transportation to carry out a study on the 
    feasibility of certain transit options in the Campbellton Road 
  transportation corridor in Atlanta, Georgia, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           December 17, 2020

   Mr. Hall introduced the following bill; which was referred to the 
             Committee on Transportation and Infrastructure

_______________________________________________________________________

                                 A BILL

 
 To direct the Secretary of Transportation to carry out a study on the 
    feasibility of certain transit options in the Campbellton Road 
  transportation corridor in Atlanta, Georgia, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. CAMPBELLTON ROAD TRANSPORTATION CORRIDOR STUDY.

    (a) In General.--The Secretary of Transportation shall conduct a 
study on the feasibility of transit options in the Campbellton Road 
transportation corridor in Atlanta, Georgia.
    (b) Contents.--In carrying out the study under subsection (a), the 
Secretary shall determine--
            (1) the feasibility of a light rail transit, heavy rail 
        transit, or bus rapid transit project in the Campbellton Road 
        transportation corridor and the extent to which such project 
        will assist in transforming such corridor of established 
        neighborhoods and businesses into a vibrant, pedestrian-
        friendly, mixed-use community and how such project could 
        incentivize major redevelopment efforts at Greenbriar Mall and 
        Fort McPherson; and
            (2) whether and which mode of transportation, light rail 
        transit, heavy rail transit, or bus rapid transit, would best 
        serve one of Atlanta, Georgia's busiest bus routes.
    (c) Report to Congress.--Not later than 1 year after the date of 
enactment of this Act, the Secretary shall submit to the Committee on 
Transportation and Infrastructure of the House of Representatives and 
the Committee on Commerce, Science, and Transportation of the Senate, 
and publish in the Federal Register, a report containing the results of 
the study under subsection (a).
                                 <all>
```
Exhibit 99.1


      Certification of Chief Executive Officer and Chief Financial Officer
             of Monument Resources, Inc. Pursuant to 18 U.S.C. 1350


     I, A.G. Foust, certify that:

     In connection with the Quarterly Report on Form 10-Q of Monument Resources,
Inc. (the "Company") for the period ended June 30, 2002 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, A.G.
Foust, Chief Executive Officer and Chief Financial Officer of the Company,
certify pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

     1.   the Report fully complies with the requirements of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934, as amended; and

     2.   the information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of the Company.


                                      Name:   A.G. Foust
                                      Title:  Chief Executive Officer and
                                              Chief Financial Officer
                                      Date:   August 13, 2002
<TABLE> <S> <C>

<PAGE>
<ARTICLE> UT
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM PUBLIC
SERVICE COMPANY OF COLORADO AND SUBSIDIARIES CONSOLIDATED CONDENSED BALANCE
SHEET AS OF DECEMBER 31, 1999 AND CONSOLIDATED  CONDENSED STATEMENTS OF INCOME
AND CASH FLOWS FOR THE YEAR ENDED DECEMBER 31, 1999 AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK> 0000081018
<NAME> PUBLIC SERVICE COMPANY OF COLORADO
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               DEC-31-1999
<BOOK-VALUE>                                  PER-BOOK
<TOTAL-NET-UTILITY-PLANT>                    4,372,536
<OTHER-PROPERTY-AND-INVEST>                    205,299
<TOTAL-CURRENT-ASSETS>                         704,151
<TOTAL-DEFERRED-CHARGES>                       306,956
<OTHER-ASSETS>                                       0
<TOTAL-ASSETS>                               5,588,942
<COMMON>                                             0
<CAPITAL-SURPLUS-PAID-IN>                    1,414,835
<RETAINED-EARNINGS>                            346,050
<TOTAL-COMMON-STOCKHOLDERS-EQ>               1,760,885
<PREFERRED-MANDATORY>                          194,000
<PREFERRED>                                          0
<LONG-TERM-DEBT-NET>                         1,721,959
<SHORT-TERM-NOTES>                                 561
<LONG-TERM-NOTES-PAYABLE>                            0
<COMMERCIAL-PAPER-OBLIGATIONS>                 355,631
<LONG-TERM-DEBT-CURRENT-PORT>                  132,823
<PREFERRED-STOCK-CURRENT>                            0
<CAPITAL-LEASE-OBLIGATIONS>                     54,257
<LEASES-CURRENT>                                 2,308
<OTHER-ITEMS-CAPITAL-AND-LIAB>               1,423,083
<TOT-CAPITALIZATION-AND-LIAB>                5,588,942
<GROSS-OPERATING-REVENUE>                    2,226,956
<INCOME-TAX-EXPENSE>                            96,574
<OTHER-OPERATING-EXPENSES>                   1,774,876
<TOTAL-OPERATING-EXPENSES>                   1,871,450
<OPERATING-INCOME-LOSS>                        355,506
<OTHER-INCOME-NET>                               4,933
<INCOME-BEFORE-INTEREST-EXPEN>                 360,439
<TOTAL-INTEREST-EXPENSE>                       156,174
<NET-INCOME>                                   204,265
<PREFERRED-STOCK-DIVIDENDS>                          0
<EARNINGS-AVAILABLE-FOR-COMM>                  204,265
<COMMON-STOCK-DIVIDENDS>                       183,428
<TOTAL-INTEREST-ON-BONDS>                      125,106
<CASH-FLOW-OPERATIONS>                         475,626
<EPS-BASIC>                                       0.00
<EPS-DILUTED>                                     0.00


</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                         411,900
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                       3,677,900
<DEPRECIATION>                               1,018,000
<TOTAL-ASSETS>                               5,356,700
<CURRENT-LIABILITIES>                           89,800
<BONDS>                                      1,097,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                   4,169,900
<TOTAL-LIABILITY-AND-EQUITY>                 5,356,700
<SALES>                                              0
<TOTAL-REVENUES>                               332,400
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                               230,700
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              52,500
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    49,200
<EPS-PRIMARY>                                     0.20
<EPS-DILUTED>                                     0.20
        

</TABLE>
# C_2023329EN.01002602.xml

| 18.9.2023 | EN | Official Journal of the European Union | C 329/26 |
| --- | --- | --- | --- |

18.9.2023

EN

Official Journal of the European Union

C 329/26

---

Order of the General Court of 27 July 2023 — Frajese v Commission

(Case T-786/22) (1)

(Action for annulment - Medicinal products for human use - Marketing authorisation for the medicinal product Spikevax - Marketing authorisation for the medicinal product Comirnaty - COVID-19 vaccine - No interest in bringing proceedings - No direct concern - No individual concern - Inadmissibility)

(2023/C 329/38)

Language of the case: Italian

Parties

Applicant: Giovanni Frajese (Rome, Italy) (represented by: O. Milanese and A. Montanari, lawyers)

Defendant: European Commission (represented by: G. Gattinara and A. Sipos, acting as Agents)

Re:

By his action under Article 263 TFEU, the applicant seeks the annulment, first, of Commission Implementing Decision C(2022) 7163 final of 3 October 2022 granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council for ‘Spikevax — elasomeran’, a medicinal product for human use and repealing Decision C(2021) 94(final) and, second, of Commission Implementing Decision C(2022) 7342 final of 10 October 2022 granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council for ‘Comirnaty — tozinameran, COVID-19 mRNA vaccine (nucleoside-modified)’, a medicinal product for human use and repealing Decision C(2020) 9598(final).

Operative part of the order

| 1. | The action is dismissed as inadmissible. |
| --- | --- |

1.

The action is dismissed as inadmissible.

| 2. | Mr Giovanni Frajese shall pay the costs. |
| --- | --- |

2.

Mr Giovanni Frajese shall pay the costs.

---

(1)  
  OJ C 63, 20.2.2023.

---
No. 11-10883.

#### Tyson *v.*United States.

C. A. 4th Cir. Cer-tiorari denied.
No. 11-10785.

#### Taylor *v.*Louisiana.

C. A. 5th Cir. Certio-rari denied.
[Federal Register Volume 62, Number 51 (Monday, March 17, 1997)]
[Notices]
[Pages 12661-12662]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-6657]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF THE INTERIOR

Fish and Wildlife Service


Endangered and Threatened Species Permit Application

AGENCY: Fish and Wildlife Service, Interior.

ACTION: Notice of receipt of application.

-----------------------------------------------------------------------

    The following applicant has applied for an amendment to her permit 
to conduct certain activities with endangered species. This notice is 
provided pursuant to section 10(c) of the Endangered Species Act of 
1973, as amended (16 U.S.C. 1531, et seq.).

PRT-801463, Amendment #2

    Applicant: Tamara Ross, Ames, Iowa.
    The applicant requests an amended permit to take (collect) Iowa 
Pleistocene snails (Discus macclintockii) in Jo

[[Page 12662]]

Davies County, Illinois. Expansion of the scope of Ms. Ross's permit is 
proposed for genetic research for the purpose of survival and 
enhancement of the species in the wild.
    Written data or comments should be submitted to the Regional 
Director, U.S. Fish and Wildlife Service, Division of Ecological 
Services Operations, 1 Federal Drive, Fort Snelling, Minnesota 55111-
4056, and must be received within 30 days of the date of this 
publication.
    Documents and other information submitted with these applications 
are available for review by any party who submits a written request for 
a copy of such documents to the following office within 30 days of the 
date of publication of this notice: U.S. Fish and Wildlife Service, 
Division of Ecological Services Operations, 1 Federal Drive, Fort 
Snelling, Minnesota 55111-4056. Telephone: (612/725-3536 x250); FAX: 
(612/725-3526).

    Dated: March 11, 1997.
Matthias A. Kerschbaum,
Acting Assistant Regional Director, IL, IN, MO (Ecological Services), 
Region 3, Fort Snelling, Minnesota.
[FR Doc. 97-6657 Filed 3-14-97; 8:45 am]
BILLING CODE 4310-55-P